These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21899446)

  • 1. Images in clinical medicine. Chemotherapy-induced hyperpigmentation of the tongue.
    Blaya M; Saba N
    N Engl J Med; 2011 Sep; 365(10):e20. PubMed ID: 21899446
    [No Abstract]   [Full Text] [Related]  

  • 2. Localized cisplatin hyperpigmentation induced by pressure. A case report.
    Al-Lamki Z; Pearson P; Jaffe N
    Cancer; 1996 Apr; 77(8):1578-81. PubMed ID: 8608546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe palmar-plantar erythema in a patient with breast cancer receiving doxorubicin-cyclophosphamide chemotherapy.
    Damasiewicz MJ; Chionh FJ; Hayes T
    Intern Med J; 2007 Jul; 37(7):505-6. PubMed ID: 17547732
    [No Abstract]   [Full Text] [Related]  

  • 4. Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy.
    Funke AA; Kulp-Shorten CL; Callen JP
    Arch Dermatol; 2010 Oct; 146(10):1113-6. PubMed ID: 20956642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of chemotherapy-induced alopecia: a review of the literature.
    Cline BW
    Cancer Nurs; 1984 Jun; 7(3):221-8. PubMed ID: 6372990
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy-induced transverse white lines in the fingernails.
    James WD; Odom RB
    Arch Dermatol; 1983 Apr; 119(4):334-5. PubMed ID: 6340614
    [No Abstract]   [Full Text] [Related]  

  • 7. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia from chemotherapy: can nursing measures help?
    Holmes W
    ANA Publ; 1979; (NP-59):223-33. PubMed ID: 259406
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide-induced nail discoloration and skin hyperpigmentation: a rare presentation.
    Chittari K; Tagboto S; Tan BB
    Clin Exp Dermatol; 2009 Apr; 34(3):405-6. PubMed ID: 18627381
    [No Abstract]   [Full Text] [Related]  

  • 10. VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer.
    Bramwell VH; Howell A; Scarffe H; Crowther D; Sellwood RA
    Cancer Treat Rep; 1982 Nov; 66(11):1999-2000. PubMed ID: 6897207
    [No Abstract]   [Full Text] [Related]  

  • 11. Docetaxel: new preparation. No first-line use in metastatic breast cancer.
    Prescrire Int; 2001 Dec; 10(56):178-9. PubMed ID: 11824441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin-induced hyperpigmentation and hypersensitivity reactions to etoposide and vinblastine in a child with endodermal sinus tumor.
    Mutafoğlu-Uysal K; Sarialioğlu F; Olgun N
    Turk J Pediatr; 2001; 43(2):172-4. PubMed ID: 11432501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peculiar pattern of nail pigmentation following cyclophosphamide therapy.
    Dave S; Thappa DM
    Dermatol Online J; 2003 Aug; 9(3):14. PubMed ID: 12952761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta).
    Matalon ST; Ornoy A; Lishner M
    Reprod Toxicol; 2004; 18(2):219-30. PubMed ID: 15019720
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of nandrolone decanoate on bone marrow suppression induced by cytostatic agents.
    Huys J; Van Vaerenbergh PM
    Clin Oncol; 1976 Sep; 2(3):207-14. PubMed ID: 1009703
    [No Abstract]   [Full Text] [Related]  

  • 18. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cardiotoxicity of anticancer agents].
    Wakasugi S
    Ryoikibetsu Shokogun Shirizu; 1996; (14):83-7. PubMed ID: 9047803
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reactivation of hepatitis B after treatment with CHOP and rituximab].
    Fernández Fernández FJ; de la Fuente Aguado J; Puerta Louro R; Fernández Villaverde A; Soto Ríos C
    Rev Clin Esp; 2007 Apr; 207(4):220. PubMed ID: 17475194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.